Back
State Street SPDR S&P Pharmaceuticals ETF Vs. ACM Research, Inc. Industry Stock Comparison
Buy
65
XPH
State Street SPDR S&P Pharmaceuticals ETF
Last Price:
$54.59
Seasonality Move:
3.02%
Sell
20
ACMR
ACM Research, Inc.
Last Price:
$40.52
Seasonality Move:
13.68%
Buy
65
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Buy
Is State Street SPDR S&P Pharmaceuticals ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Pharmaceuticals ETF [XPH] share price is $54.72. The Score for XPH is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
ACM Research, Inc. (ACMR)
is a Sell
Is ACM Research, Inc. a Buy, Sell or Hold?
-
The current ACM Research, Inc. [ACMR] share price is $40.54. The Score for ACMR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
ACMR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
XPH Stock Price Chart
What is State Street SPDR S&P Pharmaceuticals ETF's stock price today?
-
The State Street SPDR S&P Pharmaceuticals ETF share price today is $54.72The current trend is relatively stagnant and XPH is experiencing slight buying pressure.
ACMR Stock Price Chart
What is ACM Research, Inc.'s stock price today?
-
The ACM Research, Inc. share price today is $40.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACMR is experiencing slight buying pressure.
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 52 | Buy |
| Chaikin Money Flow: | 19896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.73 - 55.85) | Buy |
| Bollinger Bands (100): | (53.01 - 57.27) | Sell |
ACMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.8 | Sell |
| Relative Strength Index (14 RSI): | 36.1 | Sell |
| Chaikin Money Flow: | 278577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.39 - 50.65) | Sell |
| Bollinger Bands (100): | (35.52 - 57.1) | Sell |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Buy |
| 20-day SMA: | 53.74 | Buy |
| 50-day SMA: | 55.63 | Sell |
| 200-day SMA: | 50.28 | Buy |
| 8-day EMA: | 53.68 | Buy |
| 20-day EMA: | 54.01 | Buy |
| 50-day EMA: | 54.79 | Sell |
| 200-day EMA: | 51.39 | Buy |
ACMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.39 | Sell |
| 20-day SMA: | 44.31 | Sell |
| 50-day SMA: | 53.34 | Sell |
| 200-day SMA: | 39.17 | Buy |
| 8-day EMA: | 41.31 | Sell |
| 20-day EMA: | 44.9 | Sell |
| 50-day EMA: | 48.48 | Sell |
| 200-day EMA: | 40.92 | Sell |
State Street SPDR S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ACM Research, Inc. Earnings Growth & ACMR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.28 per share, an increase this year of $0.02 per share, and an increase next year of $0.49 per share.
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACM Research, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||